新的研究揭示了对多种骨髓瘤遗传学、免疫反应和治疗效果的关键洞察力,从而推进了个性化护理。 New research reveals key insights into multiple myeloma’s genetics, immune responses, and treatment effects, advancing personalized care.

多米奥洛马研究基金会在第22届国际米奥洛马学会年会上介绍了新的研究,展示了通过大规模研究(如COMMpassMSM和Immune Atlas)在了解该疾病方面取得的进展。 The Multiple Myeloma Research Foundation presented new research at the 22nd International Myeloma Society Annual Meeting, showcasing advances in understanding the disease through large-scale studies like CoMMpass℠ and the Immune Atlas. 调查结果揭示了对肿瘤遗传学、治疗期间的免疫反应以及影响患者结果的因素的深入了解,包括沙拉图穆马布疗法如何影响T细胞活动。 Findings revealed insights into tumor genetics, immune responses during treatment, and factors influencing patient outcomes, including how daratumumab-based therapies affect T cell activity. MMRF继续通过临床试验、合作供资和领导能力培养推动进展,目的是改善针对多位间皮瘤患者的个性化治疗和结果,这一血癌每年在美国影响数千人。 The MMRF continues to drive progress through clinical trials, collaborative funding, and leadership development, aiming to improve personalized treatments and outcomes for multiple myeloma patients, a blood cancer affecting thousands in the U.S. annually.